Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway

Palbociclib, a highly selective CDK4/6 inhibitor, has been shown to be a novel anti-tumor agent that suppresses breast cancer cell proliferation. However, its anti-metastasis activity remains controversial. In the present study, we evaluated whether palbociclib prevented breast cancer cell metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ge, Xu, Fei, Qin, Tao, Zheng, Qiufan, Shi, Dingbo, Xia, Wen, Tian, Yun, Tang, Yanlai, Wang, Jingshu, Xiao, Xiangshen, Deng, Wuguo, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747189/
https://www.ncbi.nlm.nih.gov/pubmed/26540629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747189/
https://www.ncbi.nlm.nih.gov/pubmed/26540629

Ejemplares similares